EBR Systems, Inc. (ASX: EBR)
Australia
· Delayed Price · Currency is AUD
0.920
-0.040 (-4.17%)
Nov 21, 2024, 3:59 PM AEST
EBR Systems Company Description
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation.
The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart.
Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning.
EBR Systems, Inc. was incorporated in 2003 and is based in Sunnyvale, California.
EBR Systems, Inc.
Country | United States |
Founded | 2003 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | John McCutcheon |
Contact Details
Address: 480 Oakmead Parkway Sunnyvale, Delaware 94085 United States | |
Phone | 408 720 1906 |
Website | ebrsystemsinc.com |
Stock Details
Ticker Symbol | EBR |
Exchange | Australian Securities Exchange |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | AU0000182552 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
John Graham McCutcheon B.A., M.B.A. | President, Chief Executive Officer and Director |
Allan Roger Will B.S., M.S. | Executive Chairman |
Gary W. Doherty B.S. | Chief Financial Officer |
Michael Hendricksen B.S., M.S. | Chief Operating Officer |
Dr. N. Parker Willis B.S., M.S., Ph.D. | Chief Technology Officer |
Andrew Shute B.S. | Senior Vice President of Business Development |
Dr. Spencer H. Kubo M.D. | Chief Medical Officer |
Erik Strandberg | Chief Commercial Officer |
John H. Sellers | Secretary |